Arrowstreet Capital, Limited Partnership Fibrogen Inc Transaction History

Arrowstreet Capital, Limited Partnership

  • $122 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$44.9 - $64.95 $1.82 Million - $2.64 Million
-40,602 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$45.35 - $61.65 $1.13 Million - $1.54 Million
25,002 Added 160.27%
40,602 $1.88 Million
Q4 2017

Feb 09, 2018
BUY
$41.95 - $60.1 $654,420 - $937,560
15,600
15,600 $739,000

Others Institutions Holding FGEN

# of Institutions
79
Shares Held
37.4M
Call Options Held
351K
Put Options Held
105K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email